Back to Search Start Over

Acoustic neuroma risk in relation to mobile telephone use: results of the INTERPHONE international case-control study

Authors :
L. Montestruq
Gabriele Berg-Beckhoff
Anthony J. Swerdlow
N Yamaguchi
Maria Blettner
Joachim Schüz
Neil Pearce
Louise Nadon
Anna Lahkola
C. Johansen
Daniel Krewski
Bruce K. Armstrong
Anne-Sophie Evrard
Tore Tynes
Monika Moissonnier
J Siemiatycki
Ivano Iavarone
Anders Ahlbom
Avital Jarus-Hakak
Martine Vrijheid
M. Bernard
K. G. Blaasaas
Alistair Woodward
S. J. Hepworth
Salminen T
Isabelle Deltour
J Brown
Elisabeth Cardis
Martine Hours
Angela Chetrit
Päivi Kurttio
Patricia A. McKinney
Sigrid Lönn
Maria Feychting
Lars Klaeboe
Siegal Sadetzki
Brigitte Schlehofer
Helle Collatz Christensen
Toru Takebayashi
Interphone Study Grp
Susanna Lagorio
Anssi Auvinen
G.G. Giles
Angus Cook
M. M McBride
Minouk J. Schoemaker
Marie-Élise Parent
Kenneth Muir
Institut Armand Frappier (INRS-IAF)
Institut National de la Recherche Scientifique [Québec] (INRS)-Réseau International des Instituts Pasteur (RIIP)
International Agency for Cancer Research (IACR)
IMIM-Hospital del Mar
Generalitat de Catalunya
Center for Genomic Regulation (CRG-UPF)
CIBER de Epidemiología y Salud Pública (CIBERESP)
Sydney Cancer Centre and School of Public Health
The University of Sydney
Cancer Epidemiology Centre
The Cancer Council Victoria
School of Public Health and Hospital Research Center
Centre for Population Health Risk Assessment
University of Ottawa [Ottawa]
Cancer Research Centre
BC Cancer Agency (BCCRC)
Danish Cancer Society
Institute of Cancer Epidemiology
Radiation and Nuclear Safety Authority [Helsinki] (STUK)
Département Transport, Santé, Sécurité (IFSTTAR/TS2)
Institut Français des Sciences et Technologies des Transports, de l'Aménagement et des Réseaux (IFSTTAR)-Université de Lyon
Institute of Medical Biostatistics, Epidemiology and Informatics
Johannes Gutenberg - Universität Mainz (JGU)
Department of Epidemiology and International Public Health
Universität Bielefeld = Bielefeld University-Faculty of Public Health
Unit of Environmental Epidemiology
German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ)
Cancer & Radiation Epidemiology Unit, Gertner Institute
Chaim Sheba Medical Center
National Centre for Epidemiology Surveillance and Health Promotion
National Institute of Health
Department of Preventive Medicine and Public Health
University School of Medicine
Department of Public Health
University of Otago [Dunedin, Nouvelle-Zélande]
Norwegian Radiation Protection Authority
The Cancer Registry of Norway
Norwegian Armed Forces Medical Services
The Institute of Environmental Medicine [Stockholm] (IMM)
Karolinska Institutet [Stockholm]
University of Leeds
The Health Science Research Institute
University of Warwick [Coventry]
Institute of Cancer Research
Institute of cancer research
Center for Research in Environmental Epidemiology (CREAL)
Universitat Pompeu Fabra [Barcelona] (UPF)-Catalunya ministerio de salud
This work was supported by funding from the European Fifth Framework Program, ‘Quality of Life and Management of Living Resources’ (contract QLK4-CT-1999901563) and the International Union against Cancer (UICC). The UICC received funds for this purpose from the Mobile Manufacturers’ Forum and GSM Association. Provision of funds to the INTERPHONE study investigators via the UICC was governed by agreements that guaranteed INTERPHONE's complete scientific independence. The terms of these agreements are publicly available at http://www.iarc.fr/en/research-groups/RAD/RCAd.html.The Australian centre was supported by the Australian National Health and Medical Research Council (EME Grant 219129) with funds originally derived from mobile phone service licence fees
Julianne Brown was partly supported by an Australian Postgraduate Award. Cancer Council NSW and Cancer Council Victoria provided most of the infrastructure for the project in Australia.The Canadian centres in Ottawa/Vancouver were supported by a university–industry partnership grant from the Canadian Institutes of Health Research (CIHR), the latter including partial support from the Canadian Wireless Telecommunications Association. The CIHR university–industry partnerships program also includes provisions that ensure complete scientific independence of the investigators. D. Krewski is the Natural Sciences and Engineering Research Council of Canada Chair in Risk Science at the University of Ottawa.The Canada – Montreal study was primarily funded by a grant from the Canadian Institutes of Health Research (project 15 MOP-42525). Additionally, Dr Siemiatycki's research team was partly funded by the Canada Research Chair programme and by the Guzzo-CRS Chair in Environment and Cancer. Dr Parent had a salary award from the Fonds de la recherche en santé du Québec.Additional funding for the study in France was provided by l’Association pour la Recherche sur le Cancer (ARC) [Contrat No. 5142] and three network operators (Orange, SFR, Bouygues Télécom). The funds provided by the operators represented 5% of the total cost of the French study and were governed by contracts guaranteeing the complete scientific independence of the investigators.The Finnish Interphone study received additional national funding from Emil Aaltonen Foundation and Academy of Finland (Grant No. 80921).The German Interphone study received additional national funding from the 'Deutsches Mobilfunkforschungsprogramm [German Mobile Phone Research Program]' of the German Federal Ministry of Environment, Nuclear Safety, and Nature Protection
the Ministry of Environment and Traffic of the state of Baden-Württemberg
the Ministry of Environment of the state of North Rhine-Westphalia
and the MAIFOR Programme of the University of Mainz.The Japanese Interphone study was fully funded by the Ministry of Internal Affairs and Communications of Japan.Funding in New Zealand for this project was provided by the Health Research Council of New Zealand, the Cancer Society of New Zealand, the Wellington Medical Research Foundation, the Hawke's Bay Medical Research Foundation and the Waikato Medical Research Foundation.The Swedish centre was additionally supported by the Swedish Research Council and the Swedish Cancer Society.The UK North study received additional funding from the Health and Safety Executive, the Department of Health, the Mobile Telecommunications, Health and Research (MTHR) program, and the Scottish Executive. The University of Leeds received some financial support on behalf of the 4 centres of the ‘UK North Study’ from the UK Network Operators (O2, Orange, T-Mobile, Vodafone, ‘3’) under legal signed contractual agreements which guaranteed complete independence for the scientific investigators.The Southeast England Centre wishes to acknowledge additional funding from the Mobile Telecommunications, Health and Research (MTHR) programme. The views expressed in this publication are those of the authors and not necessarily of the funders.
The INTERPHONE Study Group
Source :
Cancer Epidemiology, Biomarkers and Prevention, Cancer Epidemiology, Biomarkers and Prevention, American Association for Cancer Research, 2011, 35 (5), pp.453-64. ⟨10.1016/j.canep.2011.05.012⟩, Berg-Beckhoff, G & The INTERPHONE Study Group 2011, ' Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case-control study ', Cancer Epidemiology, vol. 35, no. 5, pp. 453-64 . https://doi.org/10.1016/j.canep.2011.05.012
Publication Year :
2011
Publisher :
HAL CCSD, 2011.

Abstract

Background: The rapid increase in mobile telephone use has generated concern about possible health risks of radiofrequency electromagnetic fields from these devices. Methods: A case-control study of 1105 patients with newly diagnosed acoustic neuroma (vestibular schwannoma) and 2145 controls was conducted in 13 countries using a common protocol. Past mobile phone use was assessed by personal interview. In the primary analysis, exposure time was censored at one year before the reference date (date of diagnosis for cases and date of diagnosis of the matched case for controls); analyses censoring exposure at five years before the reference date were also done to allow for a possible longer latent period. Results: The odds ratio (OR) of acoustic neuroma with ever having been a regular mobile phone user was 0.85 (95% confidence interval 0.69-1.04). The OR for >= 10 years after first regular mobile phone use was 0.76 (0.52-1.11). There was no trend of increasing ORs with increasing cumulative call time or cumulative number of calls, with the lowest OR (0.48 (0.30-0.78)) observed in the 9th decile of cumulative call time. In the 10th decile (>= 1640 h) of cumulative call time, the OR was 1.32 (0.88-1.97); there were, however, implausible values of reported use in those with >= 1640 h of accumulated mobile phone use. With censoring at 5 years before the reference date the OR for >= 10 years after first regular mobile phone use was 0.83 (0.58-1.19) and for >= 1640 h of cumulative call time it was 2.79(1.51-5.16). but again with no trend in the lower nine deciles and with the lowest OR in the 9th decile. In general, ORs were not greater in subjects who reported usual phone use on the same side of the head as their tumour than in those who reported it on the opposite side, but it was greater in those in the 10th decile of cumulative hours of use. Conclusions: There was no increase in risk of acoustic neuroma with ever regular use of a mobile phone or for users who began regular use 10 years or more before the reference date. Elevated odds ratios observed at the highest level of cumulative call time could be due to chance, reporting bias or a causal effect. As acoustic neuroma is usually a slowly growing tumour, the interval between introduction of mobile phones and occurrence of the tumour might have been too short to observe an effect, if there is one. (C) 2011 Elsevier Ltd. All rights reserved.

Details

Language :
English
ISSN :
10559965 and 15387755
Database :
OpenAIRE
Journal :
Cancer Epidemiology, Biomarkers and Prevention, Cancer Epidemiology, Biomarkers and Prevention, American Association for Cancer Research, 2011, 35 (5), pp.453-64. ⟨10.1016/j.canep.2011.05.012⟩, Berg-Beckhoff, G & The INTERPHONE Study Group 2011, ' Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case-control study ', Cancer Epidemiology, vol. 35, no. 5, pp. 453-64 . https://doi.org/10.1016/j.canep.2011.05.012
Accession number :
edsair.doi.dedup.....46c18c5b542707ef8c580f87e3a01373
Full Text :
https://doi.org/10.1016/j.canep.2011.05.012⟩